COMPANY PROFILE

Pfizer Inc.

Chart
Overview
Financials

Related Articles

Swine flu is replacing COVID on pharmaceutical companies’ target list
Obesity, oncology and old age: How 2023 pharmaceutical M&A is reshaping the health-care industry
The secret to Japan’s long life expectancy isn’t all about health
Amazon’s Steady Advance Into Healthcare
Seeking Forever Stocks? Consider These Three Blue Chips
In Pharma, Taking a Closer Look at Next Level Down Opportunities
A Look at Pharma M&A — Consolidating Strengths In Oncology, Immunology and More
Cash is King (But It’s Good to Be Wary of Kings)